lactic acid has been researched along with 1,2-dipalmitoylphosphatidylcholine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Giacomo, C; Fresta, M; Puglisi, G; Russo, A | 1 |
| Evora, C; Hanes, J; Langer, R; Rogers, RA; Shakesheff, KN; Soriano, I | 1 |
| Kinney, RC; Kohane, DS; Langer, R; Lipp, M; Lotan, N | 1 |
| Anthony, DC; Kinney, RC; Kohane, DS; Langer, R; Lipp, M; Lotan, N; Louis, DN | 1 |
| Dai, H; Elmquist, WF; Hitzman, CJ; Wiedmann, TS | 1 |
| Giannone, I; Montenegro, L; Musumeci, T; Pignatello, R; Puglisi, G; Ruozi, B; Ventura, CA | 1 |
| Hickey, AJ; Taylor, MK; VanOort, M | 1 |
| Besnard, M; Bochot, A; Fattal, E; Gómez-Gaete, C; Tsapis, N | 1 |
| Besnard, M; Fattal, E; Gómez-Gaete, C; Silva, L; Tsapis, N | 1 |
| Delair, T; Ladavière, C; Putaux, JL; Thevenot, J; Troutier, AL | 1 |
| Alpar, HO; Kaye, RS; Purewal, TS | 1 |
| Jin, Y; Li, B; Li, Z; Shen, H; Shen, S; Wang, X; Xie, M; Xu, H; Yao, M | 1 |
| Al Jamal, KT; Alpar, O; Awad, G; El-Shamy, AE; Kan, PL; Mortada, N; Osman, R | 1 |
| Arora, J; Boonkaew, B; Callaghan, C; Chava, S; Dash, S; He, J; John, VT; Lee, BR; Liu, J; Maddox, MM; Mandava, SH | 1 |
| Jin, Y; Li, B; Ma, W; Xu, A; Ying, J | 1 |
| Amanatiadou, EP; Bouropoulos, N; Fatouros, DG; Karavasili, C; Sygellou, L; Vizirianakis, IS | 1 |
| Cohen, O; Cordfunke, RA; de Boer, L; de Breij, A; Drijfhout, JW; Emanuel, N; Kwakman, PH; Moriarty, TF; Nibbering, PH; Riool, M; Zaat, SA | 1 |
17 other study(ies) available for lactic acid and 1,2-dipalmitoylphosphatidylcholine
| Article | Year |
|---|---|
Liposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Blood-Brain Barrier; Brain Ischemia; Cerebral Cortex; Cholesterol; Chromatography, High Pressure Liquid; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Evaluation; Lactates; Lactic Acid; Lipid Peroxidation; Liposomes; Male; Phosphatidylserines; Rats; Rats, Wistar; Reperfusion Injury; Survival Rate | 1994 |
Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cells, Cultured; Lactic Acid; Macrophages, Alveolar; Male; Microscopy, Confocal; Microspheres; Phagocytosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pulmonary Surfactants; Rats; Rats, Wistar | 1998 |
Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anesthetics, Local; Animals; Bupivacaine; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Lactic Acid; Lactose; Male; Microspheres; Nerve Block; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Serum Albumin | 2000 |
Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anesthetics, Local; Animals; Biocompatible Materials; Bupivacaine; Delayed-Action Preparations; Drug Delivery Systems; Inflammation; Lactic Acid; Lactose; Male; Microspheres; Nerve Block; Peripheral Nerves; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Serum Albumin; Time Factors | 2002 |
Measurement of drug release from microcarriers by microdialysis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Algorithms; Calibration; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Fluorouracil; Kinetics; Lactic Acid; Liposomes; Microdialysis; Microsomes; Particle Size; Pharmaceutical Preparations; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reproducibility of Results | 2005 |
PLA/PLGA nanoparticles for sustained release of docetaxel.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Delayed-Action Preparations; Diffusion; Docetaxel; Drug Compounding; Injections, Intravenous; Lactic Acid; Lipid Bilayers; Liposomes; Microscopy, Electron, Scanning; Molecular Weight; Nanoparticles; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Static Electricity; Surface Properties; Taxoids; Time Factors | 2006 |
Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particles.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Animals; Bronchodilator Agents; Cholinergic Antagonists; Drug Evaluation, Preclinical; Excipients; Female; Guinea Pigs; Ipratropium; Lactic Acid; Male; Microscopy, Electron, Scanning; Molecular Structure; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Powders; Solubility; Technology, Pharmaceutical; Time Factors; Water; X-Ray Diffraction | 2006 |
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biocompatible Materials; Calorimetry, Differential Scanning; Dexamethasone; Drug Carriers; Lactic Acid; Nanocapsules; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solvents; X-Ray Diffraction | 2007 |
Dexamethasone acetate encapsulation into Trojan particles.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anti-Inflammatory Agents; Dexamethasone; Drug Carriers; Excipients; Hyaluronic Acid; Lactic Acid; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility | 2008 |
Effect of the polymer nature on the structural organization of lipid/polymer particle assemblies.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Chemical Phenomena; Cryoelectron Microscopy; Lactic Acid; Lipid Bilayers; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Particle Size; Polyesters; Polymers; Propane; Quaternary Ammonium Compounds | 2008 |
Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Antibodies; Chemistry, Pharmaceutical; Delayed-Action Preparations; Desiccation; Drug Carriers; Drug Delivery Systems; Excipients; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lactose; Lung; Nanoparticles; Nanotechnology; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Powders; Solubility; Technology, Pharmaceutical; Time Factors; Water | 2009 |
Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2012 |
Inhalable DNase I microparticles engineered with biologically active excipients.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Animals; Chitosan; Cystic Fibrosis; Delayed-Action Preparations; Deoxyribonuclease I; Dextrans; Drug Carriers; Drug Delivery Systems; Epithelial Cells; Excipients; Lactic Acid; Macrophages; Mice; Mucus; Ovalbumin; Polyglutamic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Powders; Viscosity | 2013 |
Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Neoplasms; Kinetics; Lactic Acid; Liposomes; Nanoparticles; Nanotechnology; Niacinamide; Phenylurea Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Sorafenib; Technology, Pharmaceutical | 2015 |
Biodegradable Core-Shell Copolymer-Phospholipid Nanoparticles for Combination Chemotherapy: An In Vitro Study.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Absorbable Implants; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Nucleus; Cell Survival; Diffusion; Doxorubicin; Drug Implants; HeLa Cells; Hep G2 Cells; Humans; Lactic Acid; Nanocapsules; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome | 2015 |
PLGA/DPPC/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Intranasal; Animals; Antiparkinson Agents; Cell Line; Cell Survival; Chitosan; Drug Carriers; Humans; Indoles; Lactic Acid; Nasal Mucosa; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sheep | 2016 |
Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Cholesterol; Female; Lactic Acid; Mice, Inbred C57BL; Nail Diseases; Phosphatidylcholines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rabbits; Silicones; Staphylococcal Infections; Staphylococcus aureus | 2016 |